v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Series D Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Stock To Be Issued [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 70 $ 3 $ 1 $ 327,488 $ 114,185,329 $ (117,976,134) $ (3,463,243)
Balance, shares at Dec. 31, 2024 7,000,000 349,091 12,350 100,000 32,748,842,520          
Accrued expenses $ 11,500 1,368,500 1,380,000
Accrued expenses, shares         1,150,000,000          
Exchange of warrants $ 6,345 193,734 200,079
Exchange of warrants, shares     30   634,431,833          
Conversion of convertible notes $ 22,580 1,131,572 1,154,152
Conversion of convertible notes, shares         2,258,024,833          
Conversion of Series C Preferred to common shares $ 30,000 532,000 562,000
Conversion of Series C Preferred to common shares, shares     (758)   3,000,000,000          
Debt discount on convertible notes 539,817 539,817
Stock-based compensation - warrants 956,620 956,620
Deemed dividend (762,079) (762,079)
Net income (loss) for the period 12,840,493 12,840,493
Settlement, shares         634,431,833          
Balance at Mar. 31, 2025 $ 70 $ 3 $ 1 $ 397,913 118,907,572 (105,897,720) 13,407,839
Balance, shares at Mar. 31, 2025 7,000,000 349,091 11,622 100,000 39,791,299,186          
Balance at Dec. 31, 2024 $ 70 $ 3 $ 1 $ 327,488 114,185,329 (117,976,134) (3,463,243)
Balance, shares at Dec. 31, 2024 7,000,000 349,091 12,350 100,000 32,748,842,520          
Net income (loss) for the period                   10,023,416
Balance at Jun. 30, 2025 $ 70 $ 3 $ 1 $ 440,170 120,651,715 (108,813,297) 12,278,662
Balance, shares at Jun. 30, 2025 7,000,000 335,445 11,425 100,000 44,017,024,443          
Balance at Dec. 31, 2024 $ 70 $ 3 $ 1 $ 327,488 114,185,329 (117,976,134) (3,463,243)
Balance, shares at Dec. 31, 2024 7,000,000 349,091 12,350 100,000 32,748,842,520          
Balance at Dec. 31, 2025 $ 70 $ 3 $ 1 $ 536,188 131,203,533 200,000 (134,810,209) (2,870,414)
Balance, shares at Dec. 31, 2025 7,000,000 335,445 2,301 100,000 53,618,782,943          
Balance at Mar. 31, 2025 $ 70 $ 3 $ 1 $ 397,913 118,907,572 (105,897,720) 13,407,839
Balance, shares at Mar. 31, 2025 7,000,000 349,091 11,622 100,000 39,791,299,186          
Conversion of convertible notes $ 9,376 271,904 281,280
Conversion of convertible notes, shares         937,598,591          
Conversion of Series C Preferred to common shares $ 9,850 88,650 98,500
Conversion of Series C Preferred to common shares, shares     (197)   985,000,000          
Stock-based compensation - warrants 956,620 956,620
Deemed dividend (98,500) (98,500)
Net income (loss) for the period (2,817,077) (2,817,077)
Investment in MultiCortex $ 6,666 (6,666)
Investment in MultiCortex, shares         666,666,666          
Conversion of Series B Preferred to common shares $ 1,365 (1,365)
Conversion of Series B Preferred to common shares, shares   (13,646)     136,460,000          
Settlement $ 15,000 435,000 450,000
Settlement, shares         1,500,000,000          
Balance at Jun. 30, 2025 $ 70 $ 3 $ 1 $ 440,170 120,651,715 (108,813,297) 12,278,662
Balance, shares at Jun. 30, 2025 7,000,000 335,445 11,425 100,000 44,017,024,443          
Balance at Dec. 31, 2025 $ 70 $ 3 $ 1 $ 536,188 131,203,533 200,000 (134,810,209) (2,870,414)
Balance, shares at Dec. 31, 2025 7,000,000 335,445 2,301 100,000 53,618,782,943          
Accrued expenses $ 1,250 18,750 20,000
Accrued expenses, shares         125,000,000          
Conversion of convertible notes $ 45,000 1,105,000 1,150,000
Conversion of convertible notes, shares         4,500,000,000          
Stock-based compensation - warrants 956,620 956,620
Net income (loss) for the period (2,963,276) (2,963,276)
Cash for stock to be issued 510,000 510,000
Conversion of convertible notes for stock to be issued (issued in January 2026) $ 10,000 190,000 (200,000)
Conversion of convertible notes for stock to be issued (issued in January 2026), shares         1,000,000,000          
Stock-based compensation - options 300,000 300,000
Balance at Mar. 31, 2026 $ 70 $ 3 $ 1 $ 592,438 133,773,903 510,000 (137,773,485) (2,897,070)
Balance, shares at Mar. 31, 2026 7,000,000 335,445 2,301 100,000 59,243,782,943          
Balance at Dec. 31, 2025 $ 70 $ 3 $ 1 $ 536,188 131,203,533 200,000 (134,810,209) (2,870,414)
Balance, shares at Dec. 31, 2025 7,000,000 335,445 2,301 100,000 53,618,782,943          
Net income (loss) for the period                   (4,512,266)
Balance at Jun. 30, 2026 $ 70 $ 3 $ 1 $ 617,463 135,149,049 962,500 (139,322,475) (2,593,389)
Balance, shares at Jun. 30, 2026 7,000,000 335,445 2,301 100,000 61,746,332,657          
Balance at Mar. 31, 2026 $ 70 $ 3 $ 1 $ 592,438 133,773,903 510,000 (137,773,485) (2,897,070)
Balance, shares at Mar. 31, 2026 7,000,000 335,445 2,301 100,000 59,243,782,943          
Conversion of convertible notes $ 25,025 617,628 642,653
Conversion of convertible notes, shares         2,502,549,714          
Stock-based compensation - warrants 757,518 757,518
Net income (loss) for the period (1,548,990) (1,548,990)
Cash for stock to be issued 345,000 345,000
Services rendered for stock to be issued 107,500 107,500
Balance at Jun. 30, 2026 $ 70 $ 3 $ 1 $ 617,463 $ 135,149,049 $ 962,500 $ (139,322,475) $ (2,593,389)
Balance, shares at Jun. 30, 2026 7,000,000 335,445 2,301 100,000 61,746,332,657